CSS
ELV icon

Cubist Systematic Strategies’s Elevance Health ELV Stock Holding History

Cubist Systematic Strategies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.98M Buy
15,400
+9,300
+152% +$2.89M 0.02% 966
2025
Q2 		$2.37M Sell
6,100
-12,300
-67% -$4.95M 0.01% 1477
2025
Q1 		$8M Sell
18,400
-30,700
-63% -$12.3M 0.05% 610
2024
Q4 		$18.1M Buy
49,100
+45,800
+1,388% +$19.2M 0.11% 233
2024
Q3 		$1.72M Buy
3,300
+3,100
+1,550% +$1.66M 0.01% 1510
2024
Q2 		$108K Hold
200
– – ﹤0.01% 2616
2024
Q1 		$104K Hold
200
– – ﹤0.01% 3256
2023
Q4 		$94.3K Hold
200
– – ﹤0.01% 3188
2023
Q3 		$87.1K Buy
+200
New +$90.7K ﹤0.01% 2960
2023
Q2 		– Sell
-5,700
Closed -$2.62M – 3712
2023
Q1 		$2.62M Buy
5,700
+700
+14% +$333K 0.02% 1445
2022
Q4 		$2.56M Buy
5,000
+3,900
+355% +$1.98M 0.02% 1635
2022
Q3 		$500K Hold
1,100
– – ﹤0.01% 3160
2022
Q2 		$531K Buy
+1,100
New +$544K ﹤0.01% 3012

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Cubist Systematic Strategies's ELV Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 221 shares — an estimated $117K sold.

Cubist Systematic Strategies first reported a position in ELV in Q2 2014 and held it in 40 quarters. The position peaked at $74.5M in Q3 2023. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 221 Elevance Health shares in Q2 2024, an estimated $117K.
  • Cubist Systematic Strategies first reported a position in Elevance Health in Q2 2014 and held it in 40 quarters.
  • Cubist Systematic Strategies's Elevance Health position peaked at $74.5M in Q3 2023.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.